Cullinan Management Announces Pricing of Upsized Initial Public Offering

NEXT STORY
Cullinan Management Announces Pricing of Upsized Initial Public Offering (CORRECTION)
PREV STORY
Eldorado Gold Achieves 2020 Production Guidance; Appoints New Chair of the Board
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

New Preclinical Data Suggest That Cellectar Biosciences’ PDC Platform Provides Enhanced Outcomes in Combination with External Radiation

MADISON, Wis., Oct. 30, 2017 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB) (the “company”), ...

author_avatar
NASDAQ Market News

Mersana Therapeutics Appoints Dirk Huebner, M.D., as Chief Medical Officer

Appointment Strengthens Development Leadership to Support Growing Pipeline of Innovative ADCsCAMBRIDGE, Mass., Nov. 27, ...

author_avatar
NASDAQ Market News

INNATE PHARMA : UPCOMING INVESTOR CONFERENCES

MARSEILLE, France, April 28, 2016 (GLOBE NEWSWIRE) -- Innate Pharma SA (the "Company" - ...

author_avatar
NASDAQ Market News